Alain Vigneron, Founder & Scientific advisor - Benoît Autem, CEO - Nicolas Bodart, R&D Director - Bernard Noirhomme, Business development Manager

D-tek s.a
" "Multiplex Immuno-Dot technology for COVID-19 serological investigation The Multiplex serological technology, developed since 1995 in D-tek (www.d-tek.be), is dedicated to the profiling of the human antibody response to different immunogens, in a single test. It has various applications in laboratory diagnostics, as well as medical and pharmaceutical research (companion-diagnostics). The technology finds an obvious application for the COVID-19 serological investigation, as the antibody response to the SARS-CoV-2 infection is known to be complex, with multi-epitope targeting, and needs to be better understood. In a typical test (ongoing development), various recombinant SARS-CoV-2 antigens are coated on a membrane strip at different spot positions. The assay is designed to map, in one single test, any patient antibody recognizing any of these protein structures. The test procedure is a classical enzyme immunoassay that can be processed from 10µl of patient's serum or plasma, either manually or automated (results in 1h), and is intended to be used as: • A routine diagnostic test in clinical laboratories. • A research tool to: - map the antibody response to SARS-CoV-2 infection and analyse the spectrum of antibodies' specificities. - better understand the variability in the outcome of infection in different individuals. - distinguish between binding antibodies (Nucleocapsid) and neutralizing antibodies (S, RBD). - Stratify the risk regarding protective immunity. - Perform longitudinal serological studies of the dynamics and duration of the different antibodies. • A ""companion-diagnostic"" test for evaluation of the results of vaccine trials, and differential identification of vaccinated vs naturally immunized individuals (anti-N and anti-S differential response). • A ""companion-diagnostic"" test for the development of therapeutic antibodies. X The project is the development of a multiplex serological test for profiling the human antibody response to SARS-CoV-2 infection" "
Funding: None (Self-funding)
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it. This email address is being protected from spambots. You need JavaScript enabled to view it. This email address is being protected from spambots. You need JavaScript enabled to view it. This email address is being protected from spambots. You need JavaScript enabled to view it. www.d-tek.be

Tags: , , , , , ,